Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Vomiting 6Nausea 6Breast Neoplasms 3Neoplasms 2Hematologic Neoplasms 2Weight Loss 1Sedentary Behavior 1Postoperative Nausea and Vomiting 1Neoplasms, Plasma Cell 1Muscular Atrophy 1Multiple Endocrine Neoplasia Type 1 1Lymphoma 1Insulin Resistance 1Hyperlipidemias 1Hyperglycemia 1Delirium 1Child Nutrition Disorders 1Cachexia 1Anorexia 1Advanced Cancer 1

Interventions

ziprasidone 1Resistance Training 1Olanzapine 1Nutrition Assessment 1Monitoring, Physiologic 1Masks 1Hospitals, High-Volume 1Exercise Test 1Exercise 1Creatine 1Cognitive Behavioral Therapy 1Blood Glucose Self-Monitoring 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Sedentary Behavior × Olanzapine × Clear all
NCT00910988 2018-07-18

Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone

Washington University School of Medicine

Phase NA Completed
46 enrolled 38 charts
Endocrine

Hyperglycemia, Hyperlipidemias, Insulin Resistance, Multiple Endocrine Neoplasia Type 1, Sedentary Behavior

Data powered by HemOnc (CC BY 4.0) Colophon âš¡